B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.39 EUR 1.7%
Market Cap: 36.1m EUR
Have any thoughts about
Biohit Oyj?
Write Note

Biohit Oyj
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biohit Oyj
Cash & Cash Equivalents Peer Comparison

Comparables:
R
REG1V
M
MODU
B
BRETEC
O
OPTOMED
N
NXTMH

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Biohit Oyj
OMXH:BIOBV
Cash & Cash Equivalents
€1.8m
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
20%
R
Revenio Group Oyj
OMXH:REG1V
Cash & Cash Equivalents
€21.5m
CAGR 3-Years
-9%
CAGR 5-Years
16%
CAGR 10-Years
17%
M
Modulight Oyj
OMXH:MODU
Cash & Cash Equivalents
€409k
CAGR 3-Years
-39%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Cash & Cash Equivalents
€6.9m
CAGR 3-Years
45%
CAGR 5-Years
41%
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Cash & Cash Equivalents
€7.1m
CAGR 3-Years
-12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Cash & Cash Equivalents
€3m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A

See Also

What is Biohit Oyj's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.8m EUR

Based on the financial report for Jun 30, 2024, Biohit Oyj's Cash & Cash Equivalents amounts to 1.8m EUR.

What is Biohit Oyj's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
20%

Over the last year, the Cash & Cash Equivalents growth was 6%. The average annual Cash & Cash Equivalents growth rates for Biohit Oyj have been 22% over the past three years , 7% over the past five years , and 20% over the past ten years .

Back to Top